|
1
|
Smith RA, Andrews KS, Brooks D, Fedewa SA,
Manassaram-Baptiste D, Saslow D, Brawley OW and Wender RC: Cancer
screening in the United States, 2018: A review of current american
cancer society guidelines and current issues in cancer screening.
CA Cancer J Clin. 68:297–316. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kurian AW, Lichtensztajn DY, Keegan TH,
Nelson DO, Clarke CA and Gomez SL: Use of and mortality after
bilateral mastectomy compared with other surgical treatments for
breast cancer in California, 1998–2011. JAMA. 312:902–914. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van der Veldt AA and Smit EF: Bevacizumab
in neoadjuvant treatment for breast cancer. N Engl J Med.
366:1637–1640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leal NF, Carrara HH, Vieira KF and
Ferreira CH: Physiotherapy treatments for breast cancer-related
lymphedema: A literature review. Rev Lat Am Enfermagem. 17:730–736.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yeong J, Thike AA, Tan PH and Iqbal J:
Identifying progression predictors of breast ductal carcinoma in
situ. J Clin Pathol. 70:102–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ernster VL, Ballard-Barbash R, Barlow WE,
Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA,
Kerlikowske K, et al: Detection of ductal carcinoma in situ in
women undergoing screening mammography. J Natl Cancer Inst.
94:1546–1554. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sanders ME, Schuyler PA, Dupont WD and
Page DL: The natural history of low-grade ductal carcinoma in situ
of the breast in women treated by biopsy only revealed over 30
years of long-term follow-up. Cancer. 103:2481–2484. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abba MC, Drake JA, Hawkins KA, Hu Y, Sun
H, Notcovich C, Gaddis S, Sahin A, Baggerly K and Aldaz CM:
Transcriptomic changes in human breast cancer progression as
determined by serial analysis of gene expression. Breast Cancer
Res. 6:R499–R513. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Castro NP, Osório CA, Torres C, Bastos EP,
Mourão-Neto M, Soares FA, Brentani HP and Carraro DM: Evidence that
molecular changes in cells occur before morphological alterations
during the progression of breast ductal carcinoma. Breast Cancer
Res. 10:R872008. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schuetz CS, Michael B, Clare SE, Nieselt
K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D,
et al: Progression-specific genes identified by expression
profiling of matched ductal carcinomas in situ and invasive breast
tumors, combining laser capture microdissection and oligonucleotide
microarray analysis. Cancer Res. 66:5278–5286. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choi Y, Lee HJ, Jang MH, Gwak JM, Lee KS,
Kim EJ, Kim HJ, Lee HE and Park SY: Epithelial-mesenchymal
transition increases during the progression of in situ to invasive
basal-like breast cancer. Hum Pathol. 44:2581–2589. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shah S, Brock EJ, Jackson RM, Ji K,
Boerner JL, Sloane BF and Mattingly RR: Downregulation of Rap1Gap:
A switch from DCIS to invasive breast carcinoma via ERK/MAPK
activation. Neoplasia. 20:951–963. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sakr RA, Weigelt B, Chandarlapaty S,
Andrade VP, Guerini-Rocco E, Giri D, Ng CK, Cowell CF, Rosen N,
Reis-Filho JS and King TA: PI3K pathway activation in high-grade
ductal carcinoma in situ-implications for progression to invasive
breast carcinoma. Clin Cancer Res. 20:2326–2337. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hannemann J, Velds A, Halfwerk JB, Kreike
B, Peterse JL and van de Vijver MJ: Classification of ductal
carcinoma in situ by gene expression profiling. Breast Cancer Res.
8:R612006. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mi H, Huang X, Muruganujan A, Tang H,
Mills C, Kang D and Thomas PD: PANTHER version 11: Expanded
annotation data from gene ontology and reactome pathways, and data
analysis tool enhancements. Nucleic Acids Res. 45:D183–D189. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lesurf R, Aure MR, Mørk HH, Vitelli V;
Oslo Breast Cancer Research Consortium (OSBREAC), ; Lundgren S,
Børresen-Dale AL, Kristensen V, Wärnberg F, Hallett M and Sørlie T:
Molecular features of subtype-specific progression from ductal
carcinoma in situ to invasive breast cancer. Cell Rep.
16:1166–1179. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Green GH and Diggle PJ: On the operational
characteristics of the benjamini and hochberg false discovery rate
procedure. Stat Appl Genet Mol Biol. 6:Article272007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and
Lin CY: CytoHubba: Identifying hub objects and sub-networks from
complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meghanathan N: Correlation coefficient
analysis: Centrality vs. maximal clique size for complex real-world
network graphs. 2016. View Article : Google Scholar
|
|
24
|
Györffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tan PH: Pathology of ductal carcinoma in
situ of the breast: A heterogeneous entity in need of greater
understanding. Ann The Acad Med Singap. 30:671–677. 2001.
|
|
26
|
Gorringe KL and Fox SB: Ductal carcinoma
in situ biology, biomarkers, and diagnosis. Front Oncol. 7:2482017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chung SJ, Nagaraju GP, Nagalingam A,
Muniraj N, Kuppusamy P, Walker A, Woo J, Győrffy B, Gabrielson E,
Saxena NK and Sharma D: ADIPOQ/adiponectin induces cytotoxic
autophagy in breast cancer cells through STK11/LKB1-mediated
activation of the AMPK-ULK1 axis. Autophagy. 13:1386–1403. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Divella R, Daniele A, Mazzocca A, Abbate
I, Casamassima P, Caliandro C, Ruggeri E, Naglieri E, Sabbà C and
De Luca R: ADIPOQ rs266729 G/C gene polymorphism and plasmatic
adipocytokines connect metabolic syndrome to colorectal cancer. J
Cancer. 8:1000–1008. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Canto P, Granados JB, Feria-Bernal G,
Coral-Vázquez RM, García-García E, Tejeda ME, Tapia A, Rojano-Mejía
D and Méndez JP: PPARGC1A and ADIPOQ polymorphisms are associated
with aggressive prostate cancer in Mexican-Mestizo men with
overweight or obesity. Cancer Biomark. 19:297–303. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Delort L, Jardé T, Dubois V, Vasson MP and
Caldefie-Chézet F: New insights into anticarcinogenic properties of
adiponectin: A potential therapeutic approach in breast cancer?
Vitam Horm. 90:397–417. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He W: PPARgamma2 polymorphism and human
health. PPAR Res. 2009:8495382009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Crusz SM and Balkwill FR: Inflammation and
cancer: Advances and new agents. Nat Rev Clin Oncol. 12:584–596.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Robbins GT and Nie D: PPAR gamma,
bioactive lipids, and cancer progression. Front Biosci (Landmark
Ed). 17:1816–1834. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Khandekar MJ, Cohen P and Spiegelman BM:
Molecular mechanisms of cancer development in obesity. Nat Rev
Cancer. 11:886–895. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang S, Jiang J, Chen Z, Wang Y, Tang W,
Chen Y and Liu L: Relationship of PPARG, PPARGC1A, and PPARGC1B
polymorphisms with susceptibility to hepatocellular carcinoma in an
eastern Chinese Han population. Onco Targets Ther. 11:4651–4660.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu W, Li Y, Wang X, Chen B, Liu S, Wang Y,
Zhao W and Wu J: PPARgamma polymorphisms and cancer risk: A
meta-analysis involving 32,138 subjects. Oncol Rep. 24:579–585.
2010.PubMed/NCBI
|
|
37
|
Gallicchio L, McSorley MA, Newschaffer CJ,
Huang HY, Thuita LW, Hoffman SC and Helzlsouer KJ: Body mass,
polymorphisms in obesity-related genes, and the risk of developing
breast cancer among women with benign breast disease. Cancer Detect
Prev. 31:95–101. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu MH, Chu CH, Chou YC, Chou WY, Yang T,
Hsu GC, Yu CP, Yu JC and Sun CA: Joint effect of peroxisome
proliferator-activated receptor gamma genetic polymorphisms and
estrogen-related risk factors on breast cancer risk: Results from a
case-control study in Taiwan. Breast Cancer Res Treat. 127:777–784.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Furuhashi M: Fatty acid-binding protein 4
in cardiovascular and metabolic diseases. J Atheroscler Thromb.
26:216–232. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li H, Xiao Y, Tang L, Zhong F, Huang G, Xu
JM, Xu AM, Dai RP and Zhou ZG: Adipocyte fatty acid-binding protein
promotes palmitate-induced mitochondrial dysfunction and apoptosis
in macrophages. Front Immunol. 9:812018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhong CQ, Zhang XP, Ma N, Zhang EB, Li JJ,
Jiang YB, Gao YZ, Yuan YM, Lan SQ, Xie D and Cheng SQ: FABP4
suppresses proliferation and invasion of hepatocellular carcinoma
cells and predicts a poor prognosis for hepatocellular carcinoma.
Cancer Med. 7:2629–2640. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Davies BS, Beigneux AP, Fong LG and Young
SG: New wrinkles in lipoprotein lipase biology. Curr Opin Lipidol.
23:35–42. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Prieto D and Oppezzo P: Lipoprotein lipase
expression in chronic lymphocytic leukemia: New insights into
leukemic progression. Molecules. 22:20832017. View Article : Google Scholar
|
|
44
|
Heintel D, Kienle D, Shehata M, Kröber A,
Kroemer E, Schwarzinger I, Mitteregger D, Le T, Gleiss A,
Mannhalter C, et al: High expression of lipoprotein lipase in poor
risk B-cell chronic lymphocytic leukemia. Leukemia. 19:1216–1223.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Garofalo C and Surmacz E: Leptin and
cancer. J Cell Physiol. 207:12–22. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Garofalo C, Sisci D and Surmacz E: Leptin
interferes with the effects of the antiestrogen ICI 182,780 in
MCF-7 breast cancer cells. Clin Cancer Res. 10:6466–6475. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hu X, Juneja SC, Maihle NJ and Cleary MP:
Leptin-a growth factor in normal and malignant breast cells and for
normal mammary gland development. J Natl Cancer Inst. 94:1704–1711.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Okumura M, Yamamoto M, Sakuma H, Kojima T,
Maruyama T, Jamali M, Cooper DR and Yasuda K: Leptin and high
glucose stimulate cell proliferation in MCF-7 human breast cancer
cells: Reciprocal involvement of PKC-alpha and PPAR expression.
Biochim Biophys Acta. 1592:107–116. 2002. View Article : Google Scholar : PubMed/NCBI
|
